Search


Current filters:


Clear current filters  or Add more filters

View Option



Results 1-10 of 12 (Search time: 0.022 seconds).

  Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia (Journal article)

  Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia (Journal article)

  Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase (Journal article)

  Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes - Role of the lipoprotein-associated phospholipase A(2) and the effect of atorvastatin treatment (Journal article)

  Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with beta-thalassemia (Journal article)

  PAF-acetylhydrolase activity on Lp(a) before and during Cu2+-induced oxidative modification in vitro (Journal article)

  Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase - Implication for atherosclerosis (Journal article)

  Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures (Journal article)

  Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy (Journal article)

  Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery disease (Journal article)